查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092772

基於價值的醫療保健市場：按組成部分、支付模式、應用、最終用途、國家和地區分類－產業分析、市場規模、市場佔有率及2026年至2033年預測

Value-based Healthcare Market, By Component, By Payment Model, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 352 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，以價值為基礎的醫療保健市場規模將達到 688.97 億美元，並將在 2026 年至 2033 年期間以 10.2% 的複合年成長率成長。

價值醫療是一種強調改善病患健康結果和最佳化醫療資源利用的醫療模式。此模式關注的是醫療服務的品質和效果，而非治療或手術的數量。這種方法鼓勵醫療服務提供者與患者密切合作，提供協調一致的服務，預防可預防的疾病，並改善患者的長期健康。

基於價值的醫療保健市場—市場動態

慢性病盛行率的上升和報銷體系的擴大預計將推動市場需求。

醫療保健成本不斷上漲、慢性病盛行率日益增高，以及提高高品質醫療服務效率的需求，正促使醫療服務提供者轉向以價值為導向的醫療模式，從而推動了價值醫療市場的成長。這些模式不僅關注服務數量，更注重改善患者的健康結果。因此，各國政府、保險公司和醫療服務提供者越來越支持那些鼓勵預防性照護、早期療育和改善醫療服務連續性協調的支付系統。推動這項轉變的主要因素之一是糖尿病、心臟病和呼吸系統疾病等慢性病患者人數的不斷增加。這些疾病需要持續治療，並佔全球醫療成本的很大一部分。世界衛生組織（世衛組織）的數據顯示，慢性病導致的死亡人數佔全球死亡人數的近74%，凸顯了更有效、以病人為中心的照護策略的重要性。價值醫療透過促進積極的疾病管理和減少可預防的住院次數，有助於應對這些挑戰。

醫療服務提供者面臨越來越大的壓力，需要在有效控制成本的同時提供高品質的醫療服務，這加速了基於價值的醫療模式的普及。此外，政府、保險公司和醫療機構正增加對支付結構的投入，優先考慮病患療效、預防性照護以及加強醫療團隊間的協作。在許多地區，醫療系統正在擴大責任制醫療計劃和一次性支付項目，以促進更有效率的醫療服務。此外，私人保險公司正在推出將支付與療效掛鉤的報銷協議。遠距遠端醫療服務和遠端患者監護技術的日益普及，使醫療服務提供者能夠與患者保持聯繫，更密切地監測他們的健康狀況，並在傳統醫療機構之外提供及時的干預措施，從而進一步加速了這一轉變。

基於價值的醫療保健市場細分分析：

全球基於價值的醫療保健市場按其組成部分、支付模式、應用、最終用途和地區進行細分。

根據支付模式的不同，市場可分為四類：按次付費（P4P）、一次性付款、利潤分享計劃和其他模式。按次付費（P4P）模式佔據了支付模式細分市場的大部分佔有率。由於其易於實施且在醫療保健系統中廣受認可，基於績效的薪酬模式需求旺盛。在該模式下，醫療服務提供者因實現與醫療品質、病人安全和健康結果相關的特定目標而獲得報酬。此外，P4P 可以整合到現有的支付結構中，而無需進行重大的營運調整，這為旨在向價值醫療轉型的機構提供了一條切實可行的途徑。

基於價值的醫療保健市場—區域分析

北美在以價值為基礎的醫療保健市場中佔據了較大的收入佔有率，這得益於其先進的醫療基礎設施、數位醫療的廣泛應用以及以患者療效而非服務量為優先的強力的報銷改革。美國仍然是主要貢獻者，醫療服務提供者擴大參與旨在提高醫療品質和減少不必要支出的以價值為基礎的支付計劃。在亞太地區，醫療保健的快速現代化和保險覆蓋範圍的擴大正在推動市場需求。該地區成長的關鍵趨勢包括遠端醫療、電子健康記錄和預測分析的日益普及，以支持預防性和個人化醫療。此外，人們對預防醫學的日益重視以及應對人口老化問題的迫切需求，正在推動韓國、中國和印度等國家採用以價值為基礎的醫療保健框架。

目錄

第1章：基於價值的醫療保健市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 基於價值的醫療保健市場的主要趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：基於價值的醫療保健產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：基於價值的醫療保健市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：基於價值的醫療保健市場格局

  • 2025年基於價值的醫療保健市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 基於價值的醫療保健市場：按組成部分分類

  • 概述
    • 基於細分市場的市場佔有率分析：按組件
    • 解決方案
      • 電子健康紀錄（EHR）的整合
      • 資料分析
      • 關懷平台
    • 服務

第8章 以價值為基礎的醫療保健市場：以支付模式分類

  • 概述
    • 細分市場佔有率分析：依支付模式分類
    • 績效工資（P4P）
    • 綜合支付
    • 共享儲蓄計劃
    • 其他

第9章 基於價值的醫療保健市場：按應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 預防性醫療保健管理
    • 護理協調和病人參與
    • 風險管理
    • 其他

第10章：基於價值的醫療保健市場：以最終用途分類

  • 概述
    • 按最終用途分類的市佔率分析。
    • 醫療服務提供方
      • 醫院和診所
      • 醫生團體/ACO
    • 醫療保健支付方
    • 政府機構
    • 其他

第11章 基於價值的醫療保健市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章 主要供應商分析：基於價值的醫療保健產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • UnitedHealth Group
    • Signify Health
    • Change Healthcare/Optum
    • Athenahealth
    • Koninklijke Philips NV
    • Siemens Healthineers
    • Deloitte
    • Baker Tilly US, LLP
    • CVS Health
    • Oracle Health
    • Evolent Health
    • Veradigm
    • Cigna Healthcare
    • Humana Inc.
    • Aledade
    • Health Catalyst
    • Teladoc Health
    • Arcadia
    • Innovaccer
    • WellSky
    • MVP Healthcare
    • McKesson Corporation
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7002

Value-based Healthcare Market size was valued at USD 68,809.7 Million in 2025, expanding to a CAGR of 10.2% from 2026 to 2033.

Value-based healthcare is a model of care that emphasizes better health outcomes for patients, and the best use of healthcare resources. It is concerned with the quality and effectiveness of care, not the number of treatments or procedures. This approach encourages healthcare providers to work closely with patients, provide coordinated services, prevent illnesses that could be avoided, and improve health over the long term.

Value-based Healthcare Market- Market Dynamics

Rising prevalence of chronic disorders, and increased adoption of reimbursement frameworks are expected to propel market demand

Rising healthcare costs, the growing prevalence of chronic disorders, and the need to deliver better care more efficiently are driving healthcare organizations toward value-based care models, thereby boosting value-based healthcare market growth. Besides rewarding the volume of services provided, these models focus on achieving better health outcomes for patients. As a result, governments, insurers and health care providers are increasingly backing payment systems that incentivize preventive care, early intervention and improved coordination along the care continuum. One of the key factors behind this change is the rising number of people with chronic conditions such as diabetes, heart disease and respiratory disorders. These illnesses require ongoing treatment and account for a large share of healthcare spending worldwide. According to he World Health Organization data, chronic diseases contribute to nearly 74% of global deaths, emphasizing the importance of more effective and patient-centered care strategies. Value-based healthcare helps address these challenges by promoting proactive disease management, reducing preventable hospital visits.

Growing pressure on healthcare providers to deliver high-quality care while managing costs more effectively is accelerating the adoption of value-based healthcare models. Moreover, governments, insurers, and healthcare organizations are increasingly investing in payment structures that prioritize patient outcomes, preventive healthcare, and better coordination among care teams. Across many regions, healthcare systems are expanding accountable care initiatives and bundled payment programs to encourage more efficient care delivery. Further, private insurers are introducing reimbursement agreements that link payments to the quality of outcomes achieved. The increasing use of telehealth services and remote patient monitoring technologies is further supporting this transition by helping providers stay connected with patients, monitor their health more closely, and deliver timely interventions outside traditional healthcare settings.

Value-based Healthcare Market- Segmentation Analysis:

The Global Value-based Healthcare Market is segmented on the basis of Component, Payment Model, Application, End-Use, and Region.

The market is divided into four categories based on Payment Model: Pay-for-Performance (P4P), bundled payments, shared savings program, and others. Pay-for-Performance (P4P) segment attributed for a significant share in payment model segment. Pay-for-Performance is high in demand due to its ease of adoption and broader acceptance across healthcare systems. In this model, healthcare providers are rewarded for achieving specific goals related to care quality, patient safety, and health outcomes. Further, P4P can be incorporated into existing payment structures without requiring major operational changes, it offers a practical pathway for organizations transitioning toward value-based care.

Value-based Healthcare Market- Geographical Insights

North America holds the large chunk of revenue share of the value-based healthcare market, supported by advanced healthcare infrastructure, extensive digital health adoption, and strong reimbursement reforms that prioritize patient outcomes over service volume. The United States remains the key contributor, with healthcare providers increasingly joining in value-based payment programs designed to improve care quality and reduce unnecessary spending. In Asia Pacific, rapid healthcare modernization, expanding insurance coverage are fueling demand. A key trend shaping regional growth is the growing use of telehealth, electronic health records, and predictive analytics to support preventive and personalized care. Additionally, rising awareness of preventive healthcare and the need to manage aging populations are encouraging the adoption of value-based care frameworks across countries such as South Korea, China, India, etc.

South Korea Value-based Healthcare Market- Key Insights

South Korea's value-based healthcare market is picking up pace as the country is increasingly focusing on enhancing healthcare quality through digital innovation. Technologies like electronic medical records, artificial intelligence, advanced data analytics etc, are being increasingly adopted by hospitals and healthcare providers. The government is also supporting a more integrated approach to healthcare, particularly for older populations and those with long-term health conditions. This has led to an increased focus on quality of care, patient outcomes and overall treatment efficacy for healthcare organizations. Much of the hospital and clinic focus is on better coordination across health-care teams, improved patient experiences and reduced unnecessary medical spending.

With healthcare costs rising and the demand for better health outcomes growing, South Korea is slowly shifting away from volume-based care to models that reward quality and efficiency. Continued investments in healthcare technology, supportive policy initiatives, and a strong commitment to patient-centered care are helping drive the expansion of value-based healthcare services.

Value-based Healthcare Market- Competitive Landscape:

The value-based healthcare market is witnessing growing competition as healthcare providers, technology companies, insurers, and consulting organizations focus on delivering better patient outcomes while improving cost efficiency. Leading companies, including UnitedHealth Group, CVS Health, Veradigm, Oracle Health, and Evolent Health, are expanding their capabilities through investments in advanced analytics, care management technologies, etc. In addition, companies are increasingly pursuing partnerships, collaborations, and acquisitions to expand their service offerings and strengthen their presence in the value-based care ecosystem. These strategies are helping organizations improve care coordination, support data-driven decision-making, and meet the evolving needs of healthcare providers transitioning toward outcome-focused care models.

Recent Developments:

In January 2025, UnitedHealth Group continued to bolster its value-based care strategy through Optum, expanding the reach of its outcome-focused healthcare programs to around 4.7 million patients. The company's growing participation in value-based care reflects its focus on improving patient outcomes, enhancing care coordination, and reducing overall healthcare costs through more integrated and preventive care approaches.

In May 2025, CVS Health (Aetna) enhanced its value-based healthcare approach by launching new care coordination initiatives designed to streamline patient care. The company introduced bundled authorization processes for selected cancer-related diagnostic services and expanded its Clinical Collaboration program.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VALUE-BASED HEALTHCARE MARKET KEY PLAYERS

  • UnitedHealth Group
  • Signify Health
  • Change Healthcare / Optum
  • Athenahealth
  • Koninklijke Philips N.V.
  • Siemens Healthineers
  • Deloitte
  • Baker Tilly US, LLP
  • CVS Health
  • Oracle Health
  • Evolent Health
  • Veradigm
  • Cigna Healthcare
  • Humana Inc.
  • Aledade
  • Health Catalyst
  • Teladoc Health
  • Arcadia
  • Innovaccer
  • WellSky
  • MVP Healthcare
  • McKesson Corporation
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY COMPONENT- MARKET ANALYSIS, 2020-2033

  • Solution
  • Electronic Health Records (EHR) Integration
  • Data Analytics
  • Care Platforms
  • Services

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY PAYMENT MODEL- MARKET ANALYSIS, 2020-2033

  • Pay-for-Performance (P4P)
  • Bundled payments
  • Shared savings program
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Preventive Care Management
  • Care Co-ordination & Patient Engagement
  • Risk Management
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

  • Healthcare Providers
  • Hospitals & Clinics
  • Physician Groups / ACOs
  • Healthcare Payers
  • Government Organizations
  • Others

GLOBAL VALUE-BASED HEALTHCARE MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Value-based Healthcare Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Value-based Healthcare Market Snippet by Component
    • 2.1.2. Value-based Healthcare Market Snippet by Payment Model
    • 2.1.3. Value-based Healthcare Market Snippet by Application
    • 2.1.4. Value-based Healthcare Market Snippet by End-Use
    • 2.1.5. Value-based Healthcare Market Snippet by Country
    • 2.1.6. Value-based Healthcare Market Snippet by Region
  • 2.2. Competitive Insights

3. Value-based Healthcare Key Market Trends

  • 3.1. Value-based Healthcare Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Value-based Healthcare Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Value-based Healthcare Market Opportunities
  • 3.4. Value-based Healthcare Market Future Trends

4. Value-based Healthcare Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Value-based Healthcare Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Value-based Healthcare Market Landscape

  • 6.1. Value-based Healthcare Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Value-based Healthcare Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Solution
      • 7.1.2.1. Electronic Health Records (EHR) Integration
      • 7.1.2.2. Data Analytics
      • 7.1.2.3. Care Platforms
    • 7.1.3. Services

8. Value-based Healthcare Market - By Payment Model

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Payment Model, 2025 & 2033 (%)
    • 8.1.2. Pay-for-Performance (P4P)
    • 8.1.3. Bundled payments
    • 8.1.4. Shared savings program
    • 8.1.5. Others

9. Value-based Healthcare Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Preventive Care Management
    • 9.1.3. Care Co-ordination & Patient Engagement
    • 9.1.4. Risk Management
    • 9.1.5. Others

10. Value-based Healthcare Market - By End-Use

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
    • 10.1.2. Healthcare Providers
      • 10.1.2.1. Hospitals & Clinics
      • 10.1.2.2. Physician Groups / ACOs
    • 10.1.3. Healthcare Payers
    • 10.1.4. Government Organizations
    • 10.1.5. Others

11. Value-based Healthcare Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Value-based Healthcare Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Value-based Healthcare Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Value-based Healthcare Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Value-based Healthcare Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Value-based Healthcare Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Payment Model, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Value-based Healthcare Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. UnitedHealth Group
    • 12.2.2. Signify Health
    • 12.2.3. Change Healthcare / Optum
    • 12.2.4. Athenahealth
    • 12.2.5. Koninklijke Philips N.V.
    • 12.2.6. Siemens Healthineers
    • 12.2.7. Deloitte
    • 12.2.8. Baker Tilly US, LLP
    • 12.2.9. CVS Health
    • 12.2.10. Oracle Health
    • 12.2.11. Evolent Health
    • 12.2.12. Veradigm
    • 12.2.13. Cigna Healthcare
    • 12.2.14. Humana Inc.
    • 12.2.15. Aledade
    • 12.2.16. Health Catalyst
    • 12.2.17. Teladoc Health
    • 12.2.18. Arcadia
    • 12.2.19. Innovaccer
    • 12.2.20. WellSky
    • 12.2.21. MVP Healthcare
    • 12.2.22. McKesson Corporation
    • 12.2.23. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us